ED vs PRLD · P/E 18, rev $15.26B vs rev $6.5M
Consolidated Edison Inc (ED) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the ED and PRLD stock pages for the full models.
Not investment advice.